Chemed Co. (NYSE:CHE - Get Free Report) CEO Kevin J. Mcnamara sold 1,000 shares of the company's stock in a transaction that occurred on Monday, March 31st. The stock was sold at an average price of $615.33, for a total value of $615,330.00. Following the transaction, the chief executive officer now directly owns 101,679 shares in the company, valued at $62,566,139.07. The trade was a 0.97 % decrease in their ownership of the stock. The sale was disclosed in a document filed with the Securities & Exchange Commission, which is available through the SEC website.
Chemed Stock Up 0.5 %
Shares of NYSE:CHE opened at $618.14 on Wednesday. The business's 50 day moving average is $576.54 and its 200 day moving average is $567.29. Chemed Co. has a 12-month low of $512.12 and a 12-month high of $639.61. The stock has a market cap of $9.05 billion, a price-to-earnings ratio of 31.23, a PEG ratio of 2.15 and a beta of 0.43.
Chemed Dividend Announcement
The company also recently disclosed a quarterly dividend, which was paid on Friday, March 14th. Shareholders of record on Monday, February 24th were issued a dividend of $0.50 per share. This represents a $2.00 dividend on an annualized basis and a yield of 0.32%. The ex-dividend date of this dividend was Monday, February 24th. Chemed's dividend payout ratio is 10.05%.
Institutional Trading of Chemed
Institutional investors and hedge funds have recently made changes to their positions in the company. Neuberger Berman Group LLC boosted its holdings in Chemed by 1.2% during the fourth quarter. Neuberger Berman Group LLC now owns 501,562 shares of the company's stock worth $265,726,000 after purchasing an additional 5,809 shares during the last quarter. State Street Corp boosted its stake in shares of Chemed by 0.8% in the 3rd quarter. State Street Corp now owns 464,354 shares of the company's stock worth $279,063,000 after buying an additional 3,564 shares during the last quarter. Geode Capital Management LLC grew its holdings in shares of Chemed by 1.5% in the fourth quarter. Geode Capital Management LLC now owns 340,409 shares of the company's stock valued at $180,654,000 after acquiring an additional 4,966 shares in the last quarter. FMR LLC increased its position in shares of Chemed by 18.9% during the fourth quarter. FMR LLC now owns 283,790 shares of the company's stock valued at $150,352,000 after acquiring an additional 45,174 shares during the last quarter. Finally, JPMorgan Chase & Co. lifted its holdings in Chemed by 8.2% during the fourth quarter. JPMorgan Chase & Co. now owns 266,786 shares of the company's stock worth $141,343,000 after acquiring an additional 20,310 shares during the period. Hedge funds and other institutional investors own 95.85% of the company's stock.
Wall Street Analyst Weigh In
A number of analysts have commented on the stock. StockNews.com upgraded shares of Chemed from a "hold" rating to a "buy" rating in a research note on Friday, March 7th. Royal Bank of Canada upped their target price on shares of Chemed from $633.00 to $667.00 and gave the stock an "outperform" rating in a report on Friday, March 14th.
Get Our Latest Analysis on CHE
Chemed Company Profile
(
Get Free Report)
Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.
Featured Articles
This instant news alert was generated by narrative science technology and financial data from InsiderTrades.com in order to provide readers with the fastest and most accurate reporting. This story was reviewed by InsiderTrades.com's editorial team prior to publication. Please send any questions or comments about this story to contact@insidertrades.com.
